Policy ForumEthics: COVID-19
COVID-19 vaccine trial ethics once we have efficacious vaccines
See allHide authors and affiliations
Science 11 Dec 2020:
Vol. 370, Issue 6522, pp. 1277-1279
DOI: 10.1126/science.abf5084
Vol. 370, Issue 6522, pp. 1277-1279
DOI: 10.1126/science.abf5084
David Wendler
1Department of Bioethics, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, USA.
Jorge Ochoa
1Department of Bioethics, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, USA.
Joseph Millum
1Department of Bioethics, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, USA.
2Fogarty International Center, NIH, Bethesda, MD, USA.
Christine Grady
1Department of Bioethics, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, USA.
Holly A. Taylor
1Department of Bioethics, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, USA.